Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one ...
Moderna chief executive officer Stéphane Bancel steps down as chief commercial officer, with president Stephen Hoge assuming ...
A source tells Bloomberg that Stephane Bancel will step down as the company’s Chief Commercial Officer, but retain the role of ...
Hosted on MSN1d
Moderna’s mRESVIA vaccine gains Health Canada approvalModerna CEO Stéphane Bancel said: "Today's approval is an example of how our mRNA platform can help address significant ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
Moderna shares rose Thursday morning after reporting better results than expected for the third quarter. The vaccine maker ...
"We are honored to be recognized by BioSpace as the most desirable large employer in the life sciences industry for the fourth year in a row," said Stéphane Bancel, Chief Executive Officer of Moderna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback